Detalles de la búsqueda
1.
Imaging of inflammatory cellular protagonists in human atherosclerosis: a dual-isotope SPECT approach.
Eur J Nucl Med Mol Imaging
; 47(12): 2856-2865, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32291511
2.
The LFA-1 antagonist BIRT377 reverses neuropathic pain in prenatal alcohol-exposed female rats via actions on peripheral and central neuroimmune function in discrete pain-relevant tissue regions.
Brain Behav Immun
; 87: 339-358, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31918004
3.
Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors.
FASEB J
; 30(5): 1880-91, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26864854
4.
Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
Ann Allergy Asthma Immunol
; 108(3): 195-200, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22374204
5.
Regional particle size dependent deposition of inhaled aerosols in rats and mice.
Inhal Toxicol
; 24(1): 27-35, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22145784
6.
Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization.
Mol Pharm
; 7(4): 1274-82, 2010 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20575527
7.
Current Status and Best Practices of Shared Governance in US Pharmacy Programs.
Am J Pharm Educ
; 84(7): ajpe7281, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32773821
8.
Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties.
J Med Chem
; 63(19): 10984-11011, 2020 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32902275
9.
Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy.
Cell Rep
; 30(6): 1798-1810.e4, 2020 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32049011
10.
LFA-1 antagonist (BIRT377) similarly reverses peripheral neuropathic pain in male and female mice with underlying sex divergent peripheral immune proinflammatory phenotypes.
Neuroimmunol Neuroinflamm
; 62019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31763376
11.
Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers.
J Nucl Med
; 49(6): 978-86, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18483091
12.
Enhancement of somatostatin-receptor-targeted (177)Lu-[DOTA(0)-Tyr(3)]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation.
Nucl Med Biol
; 35(6): 673-8, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18678352
13.
A performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United States.
Appl Radiat Isot
; 66(2): 252-60, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17933545
14.
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations.
Target Oncol
; 13(2): 189-203, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29423595
15.
Optimizing the radiosynthesis of [68Ga]DOTA-MLN6907 peptide containing three disulfide cyclization bonds - a GCC specific chelate for clinical radiopharmaceuticals.
Appl Radiat Isot
; 140: 333-341, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30138815
16.
111In-DANBIRT In Vivo Molecular Imaging of Inflammatory Cells in Atherosclerosis.
Contrast Media Mol Imaging
; 2018: 6508724, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30538613
17.
Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pharmacotherapy
; 27(3): 343-50, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17316146
18.
Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
Nucl Med Biol
; 34(2): 185-93, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17307126
19.
213Bi-[DOTA0, Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model.
Clin Cancer Res
; 12(3 Pt 1): 897-903, 2006 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16467104
20.
Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy.
EJNMMI Radiopharm Chem
; 1(1): 9, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29564386